Cas:156469-74-8 diethyl (3R,4S)-1-benzylpyrrolidine-3,4-dicarboxylate manufacturer & supplier

Chemical Name:diethyl (3R,4S)-1-benzylpyrrolidine-3,4-dicarboxylate

CAS.NO:156469-74-8

Synonyms:Diethyl cis-1-benzyl-3,4-pyrrolidinedicarboxylate;cis-Diethyl 1-benzylpyrrolidine-3,4-dicarboxylate

Molecular Formula:C₁₇H₂₃NO₄

Molecular Weight:305.36900

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:

PSA:55.84000

Exact Mass:305.16300

LogP:1.79870

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like Diethyl cis-1-benzyl-3,4-pyrrolidinedicarboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,cis-Diethyl 1-benzylpyrrolidine-3,4-dicarboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,cis-Diethyl 1-benzylpyrrolidine-3,4-dicarboxylate Use and application,Diethyl cis-1-benzyl-3,4-pyrrolidinedicarboxylate technical grade,usp/ep/jp grade.

Related News: Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance. diethyl (3R,4S)-1-benzylpyrrolidine-3,4-dicarboxylate manufacturer It found that about 5% of both groups of women have a genetic mutation that increases the risk of breast cancer. diethyl (3R,4S)-1-benzylpyrrolidine-3,4-dicarboxylate supplier The company memo said Lilly couldn’t substantiate allegations that employees faced retaliation for refusing to make false statements. It did not address employees’ specific complaints that they faced retaliation for other reasons, other than to say it encouraged employees to “speak up.” diethyl (3R,4S)-1-benzylpyrrolidine-3,4-dicarboxylate vendor The insulin-only and bihormonal configurations may be helpful in diabetes. diethyl (3R,4S)-1-benzylpyrrolidine-3,4-dicarboxylate factory Exceeding impurities in the drug substance may cause the product and its preparation to be recalled. The company receives an FDA warning letter or a CEP certificate suspension, which in turn will cause customer compensation, product recall costs, and asset impairment losses to affect the company’s performance.